123 related articles for article (PubMed ID: 16725221)
1. Dose painting: art or science?
Tanderup K; Olsen DR; Grau C
Radiother Oncol; 2006 Jun; 79(3):245-8. PubMed ID: 16725221
[No Abstract] [Full Text] [Related]
2. Future issues in highly conformal radiotherapy for head and neck cancer.
Feng M; Eisbruch A
J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
4. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
5. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
6. The overuse of intensity-modulated radiotherapy and the role of the healthcare payer.
Loblaw DA
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):459-60. PubMed ID: 22722057
[No Abstract] [Full Text] [Related]
7. Beware the swing and a miss: baseball precautions for conformal radiotherapy.
Harari PM
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):657-9. PubMed ID: 18262084
[No Abstract] [Full Text] [Related]
8. Intensity-modulated radiation therapy.
Lee NY; Terezakis SA
J Surg Oncol; 2008 Jun; 97(8):691-6. PubMed ID: 18493919
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated radiation therapy (IMRT)--a new approach to external beam RT.
Hevezi JM; Morin RL
J Am Coll Radiol; 2004 Mar; 1(3):221-2. PubMed ID: 17411565
[No Abstract] [Full Text] [Related]
10. Commentary: IMRT for head and neck cancer: many chapters left to write.
Allen AM; Tishler RB
Oncologist; 2007 May; 12(5):565-8. PubMed ID: 17522244
[No Abstract] [Full Text] [Related]
11. Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer.
Chen J; Shrieve DC; Hitchcock YJ
Radiother Oncol; 2008 May; 87(2):274-80. PubMed ID: 18206257
[TBL] [Abstract][Full Text] [Related]
12. Sparing submandibular gland by IMRT.
Saibishkumar EP; Jha N
Radiother Oncol; 2006 Jul; 80(1):106. PubMed ID: 16876273
[No Abstract] [Full Text] [Related]
13. Impact of dose and volume on radiation-induced mucositis.
Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
Rays; 2005; 30(2):137-44. PubMed ID: 16294906
[TBL] [Abstract][Full Text] [Related]
14. Reducing treatment side effects for head and neck cancer.
Br Dent J; 2005 Nov; 199(9):555. PubMed ID: 16288244
[No Abstract] [Full Text] [Related]
15. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
16. Omni-wedge technique for increased dose homogeneity in head and neck radiotherapy.
Vinagre FL; Simões PC; Rachinhas PJ
Phys Med; 2009 Sep; 25(3):154-9. PubMed ID: 19299178
[TBL] [Abstract][Full Text] [Related]
17. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy of head-and-neck cancer: encouraging early results.
Eisbruch A
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):1-3. PubMed ID: 12007933
[No Abstract] [Full Text] [Related]
19. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
